These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 31714739)

  • 21. Interaction between tachyplesin I, an antimicrobial peptide derived from horseshoe crab, and lipopolysaccharide.
    Kushibiki T; Kamiya M; Aizawa T; Kumaki Y; Kikukawa T; Mizuguchi M; Demura M; Kawabata S; Kawano K
    Biochim Biophys Acta; 2014 Mar; 1844(3):527-34. PubMed ID: 24389234
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tachyplesin, a class of antimicrobial peptide from the hemocytes of the horseshoe crab (Tachypleus tridentatus). Isolation and chemical structure.
    Nakamura T; Furunaka H; Miyata T; Tokunaga F; Muta T; Iwanaga S; Niwa M; Takao T; Shimonishi Y
    J Biol Chem; 1988 Nov; 263(32):16709-13. PubMed ID: 3141410
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Solution and micelle-bound structures of tachyplesin I and its active aromatic linear derivatives.
    Laederach A; Andreotti AH; Fulton DB
    Biochemistry; 2002 Oct; 41(41):12359-68. PubMed ID: 12369825
    [TBL] [Abstract][Full Text] [Related]  

  • 24. RGD-Tachyplesin inhibits tumor growth.
    Chen Y; Xu X; Hong S; Chen J; Liu N; Underhill CB; Creswell K; Zhang L
    Cancer Res; 2001 Mar; 61(6):2434-8. PubMed ID: 11289111
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mechanism of tachyplesin I injury to bacterial membranes and intracellular enzymes, determined by laser confocal scanning microscopy and flow cytometry.
    Hong J; Guan W; Jin G; Zhao H; Jiang X; Dai J
    Microbiol Res; 2015 Jan; 170():69-77. PubMed ID: 25267486
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tachyplesin and anti-lipopolysaccharide factor.
    Muta T; Iwanaga S
    Methods Mol Biol; 1997; 78():63-71. PubMed ID: 9276297
    [No Abstract]   [Full Text] [Related]  

  • 27. Bacteria-selective synergism between the antimicrobial peptides alpha-helical magainin 2 and cyclic beta-sheet tachyplesin I: toward cocktail therapy.
    Kobayashi S; Hirakura Y; Matsuzaki K
    Biochemistry; 2001 Dec; 40(48):14330-5. PubMed ID: 11724544
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Peptide-mediated leishmaniasis management strategy: Tachyplesin emerges as an effective anti-leishmanial peptide against Leishmania donovani.
    Kumar V; Chugh A
    Biochim Biophys Acta Biomembr; 2021 Aug; 1863(8):183629. PubMed ID: 33933430
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influences of disulfide connectivity on structure and antimicrobial activity of tachyplesin I.
    Shi J; So LY; Chen F; Liang J; Chow HY; Wong KY; Wan S; Jiang T; Yu R
    J Pept Sci; 2018 Jun; 24(6):e3087. PubMed ID: 29870123
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mode of action of an antimicrobial peptide, tachyplesin I, on biomembranes.
    Katsu T; Nakao S; Iwanaga S
    Biol Pharm Bull; 1993 Feb; 16(2):178-81. PubMed ID: 7689887
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Trypanocidal and leishmanicidal activities of different antimicrobial peptides (AMPs) isolated from aquatic animals.
    Löfgren SE; Miletti LC; Steindel M; Bachère E; Barracco MA
    Exp Parasitol; 2008 Feb; 118(2):197-202. PubMed ID: 17888907
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quantitative Proteomic Profiling of Tachyplesin I Targets in U251 Gliomaspheres.
    Li X; Dai J; Tang Y; Li L; Jin G
    Mar Drugs; 2017 Jan; 15(1):. PubMed ID: 28106765
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of recombinant tachyplesin I in Pichia pastoris.
    Li H; Ali Z; Liu X; Jiang L; Tang Y; Dai J
    Protein Expr Purif; 2019 May; 157():50-56. PubMed ID: 30711625
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Conformations and orientations of aromatic amino acid residues of tachyplesin I in phospholipid membranes.
    Oishi O; Yamashita S; Nishimoto E; Lee S; Sugihara G; Ohno M
    Biochemistry; 1997 Apr; 36(14):4352-9. PubMed ID: 9100032
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Design of salt-insensitive glycine-rich antimicrobial peptides with cyclic tricystine structures.
    Tam JP; Lu YA; Yang JL
    Biochemistry; 2000 Jun; 39(24):7159-69. PubMed ID: 10852714
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antiviral function of Tachyplesin I against iridovirus and nodavirus.
    Xie H; Wei J; Qin Q
    Fish Shellfish Immunol; 2016 Nov; 58():96-102. PubMed ID: 27633674
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Redesigned Spider Peptide with Improved Antimicrobial and Anticancer Properties.
    Troeira Henriques S; Lawrence N; Chaousis S; Ravipati AS; Cheneval O; Benfield AH; Elliott AG; Kavanagh AM; Cooper MA; Chan LY; Huang YH; Craik DJ
    ACS Chem Biol; 2017 Sep; 12(9):2324-2334. PubMed ID: 28741926
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficient delivery of anti-miR-210 using Tachyplesin, a cell penetrating peptide, for glioblastoma treatment.
    Jana A; Narula P; Chugh A; Kulshreshtha R
    Int J Pharm; 2019 Dec; 572():118789. PubMed ID: 31726199
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cytotoxic Potential of the Novel Horseshoe Crab Peptide Polyphemusin III.
    Marggraf MB; Panteleev PV; Emelianova AA; Sorokin MI; Bolosov IA; Buzdin AA; Kuzmin DV; Ovchinnikova TV
    Mar Drugs; 2018 Nov; 16(12):. PubMed ID: 30486233
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Conformation of tachyplesin I from Tachypleus tridentatus when interacting with lipid matrices.
    Park NG; Lee S; Oishi O; Aoyagi H; Iwanaga S; Yamashita S; Ohno M
    Biochemistry; 1992 Dec; 31(48):12241-7. PubMed ID: 1457421
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.